Laser for retina disease goes to trial
November 26th 2007Results of a clinical trial investigating Ellex's non-thermal Retina Regeneration Therapy (2RT), demonstrates the therapy's potential to improve and stabilize visual acuity (VA) and reduce retinal oedema in patients with diabetic maculopathy and macular oedema without causing damage to photoreceptors.
Lipid modifying drug found to protect diabetic eye
November 26th 2007Results published online by The Lancet, from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study have revealed that fenofibrate is the first lipid modifying agent found to reduce the risk of diabetic retinopathy.
AMD supplements increase smokers' risk of cancer
November 20th 2007Smokers with age-related macular degeneration (AMD) should not be taking the age-related eye disease study (AREDS) formulation of vitamins and antioxidants, as it puts them at an increased risk of developing lung cancer, according to a presentation given at the Retina Subspecialty Day of this year's AAO congress in New Orleans, US.
Routine NSAID use questioned based on multiple factors
November 12th 2007Topical nonsteroidal anti-inflammatory drugs (NSAIDs) are often used off-label for multiple purposes in cataract surgery, but such treatment is often being administered with limited supporting evidence and carries a high cost along with potential risks.
Concomitant therapy of epiretinal radiation, bevacizumab for neovascular AMD promising
November 12th 2007Concomitant delivery of focal radiotherapy and bevacizumab (Avastin, Genentech) showed promise in a small multicenter feasibility study of patients with neovascular age-related macular degeneration.